Impact of Chia Seeds on Human Breast Milk Composition (NCT07343908)
An RCT: Impact of Chia Seeds on Human Breast Milk Composition
🩺 Plain-English Summary (8th-Grade Level)
The investigators' over-arching hypothesis is that mechanical and compositional properties of chia seeds supplemented during lactation diminish obesity-induced intestinal inflammation and barrier dysfunction. The investigators hypothesize these changes will result in: 1) reduced maternal systemic inflammation (serum CRP and IL-6) and increased gut microbial diversity and richness, 2) reduced HM fat and inflammatory markers, metrics the research team have demonstrated differ in tandem with maternal metabolic health and 3) improved infant growth/body composition. To test these hypotheses, investigators will evaluate chia seed supplementation during lactation in a 6wk multi-site pilot RCT (Aim 1) and through translational studies using human enteroids (Aim 2).
Who can join: Review the eligibility criteria below.
Location: Brigham and Womens Hospital — Boston, Massachusetts
Age range: 18 Years to 45 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (2 Sites)
- Brigham and Womens Hospital — Boston, Massachusetts
- University of Oklahoma Health Sciences Center — Oklahoma City, Oklahoma
📞 Contact the Study Coordinator
Phone: (405) 271-2767
Email: david-fields@ou.edu
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Obesity and Overweight
- Efficacy and Safety of MET097 Once-Weekly in People With Overweight or Obesity — Scottsdale, Arizona
- Safety and Efficacy of NA-931 and Tirzepatide in Adults Who Are Overweight or Obese — Los Angeles, California
- Brain and Behavior Influences on Obesity Development From Infancy Through Childhood — Baltimore, Maryland
- FAMily-centered WEight Loss for Black Adults (FAM WEL B-ing) — Chapel Hill, North Carolina
- Metabotyping of Broccoli Microgreen in Obese Breast Cancer Survivors — Baltimore, Maryland
Explore by condition: All Obesity and Overweight clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.